These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31889326)

  • 41. Restoration of sweating disturbance in atopic dermatitis treated with dupilumab.
    Mizukawa Y; Sato Y; Ohyama M; Shiohara T
    J Dermatol Sci; 2020 Oct; 100(1):79-81. PubMed ID: 32900571
    [No Abstract]   [Full Text] [Related]  

  • 42. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema.
    Crepy MN; Nosbaum A; Bensefa-Colas L
    Contact Dermatitis; 2019 Aug; 81(2):145-147. PubMed ID: 30851059
    [No Abstract]   [Full Text] [Related]  

  • 43. Dupilumab in a child with severe atopic dermatitis and severe asthma-a rare case with severe limbitis and exercise-induced anaphylaxis.
    Poelhekken M; Rosenberg FM; Oldhoff JM; Romeijn GLE; Wijdh RHJ; Bocca-Tjeertes IFA; Schuttelaar MLA
    Int J Dermatol; 2022 Oct; 61(10):e400-e401. PubMed ID: 35567488
    [No Abstract]   [Full Text] [Related]  

  • 44. Dupilumab for atopic dermatitis in children with idiopathic nephrotic syndrome treated with cyclosporin: a report of two cases.
    Lucca MB; Recuero JK; Lorenzini D; Weber MB
    Australas J Dermatol; 2024 May; 65(3):292-294. PubMed ID: 38421886
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of atopic dermatitis with dupilumab in Taiwan: dynamic changes of IgE levels as a potential response biomarker.
    Huang TH; Chen YC; Lin SY; Chiu SH; Yang TT; Chiu LW; Chen YY; Lan CE
    Eur J Dermatol; 2019 Dec; 29(6):658-659. PubMed ID: 31903962
    [No Abstract]   [Full Text] [Related]  

  • 46. Aarskog-Scott syndrome and atopic dermatitis successfully treated with dupilumab: a casual presentation?
    Calabrese G; Licata G; Buononato D; Gambardella A; De Rosa A; Argenziano G
    Clin Exp Dermatol; 2022 Feb; 47(2):452-453. PubMed ID: 34482546
    [No Abstract]   [Full Text] [Related]  

  • 47. [Analysis of a case series of adult patients with severe atopic dermatitis treated with dupilumab in Argentina].
    Máspero J; Angles MV; Ardusso L; Brancciforte M; Castro C; Cruz Iturrieta C; Chouela E; De Gennaro MS; Fernández Bussy R; Galimberti ML; Galimberti RL; Gattolin G; Luna PC; Magariños G; Marini MG; Maskin M; Plafnik R; Raimondo N; Russo JP; Sevinsky L; Stringa MF
    Rev Fac Cien Med Univ Nac Cordoba; 2020 Jun; 77(2):94-99. PubMed ID: 32558511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis.
    Kim NS; Maliyar K; Oliveira L; O'Toole A; Gooderham MJ
    Int J Dermatol; 2020 Oct; 59(10):e361-e363. PubMed ID: 32772360
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome.
    Lévy R; Béziat V; Barbieux C; Puel A; Bourrat E; Casanova JL; Hovnanian A
    J Clin Immunol; 2020 Feb; 40(2):418-420. PubMed ID: 31993867
    [No Abstract]   [Full Text] [Related]  

  • 50. Rapid disappearance of both severe atopic dermatitis and cold urticaria following dupilumab treatment.
    Ferrucci S; Benzecry V; Berti E; Asero R
    Clin Exp Dermatol; 2020 Apr; 45(3):345-346. PubMed ID: 31437869
    [No Abstract]   [Full Text] [Related]  

  • 51. The cost of dupilumab treatment for severe atopic dermatitis is largely offset by broader health-care savings and improvement in quality of life.
    Edwards HA; McMeniman EK
    Australas J Dermatol; 2020 May; 61(2):e273-e275. PubMed ID: 32084290
    [No Abstract]   [Full Text] [Related]  

  • 52. Dupilumab therapy rapidly improved alopecia areata associated with trichotillomania in an atopic dermatitis patient.
    Ushida M; Ohshita A; Arakawa Y; Kanehisa F; Katoh N; Asai J
    Allergol Int; 2020 Jul; 69(3):480-482. PubMed ID: 32234288
    [No Abstract]   [Full Text] [Related]  

  • 53. Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis.
    Fowler E; Rosen J; Lev-Tov H; Yosipovitch G
    Acta Derm Venereol; 2019 Sep; 99(10):899-900. PubMed ID: 31037315
    [No Abstract]   [Full Text] [Related]  

  • 54. Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion.
    Thyssen JP; de Bruin-Weller MS; Paller AS; Leshem YA; Vestergaard C; Deleuran M; Drucker AM; Foelster-Holst R; Traidl-Hoffmann C; Eyerich K; Taieb A; Su JC; Bieber T; Cork MJ; Eichenfield LF; Guttman-Yassky E; Wollenberg A
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1224-1231. PubMed ID: 31056788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dupilumab-related Granulomatous Dermatitis.
    Omer M; Khadra SB; DiMarco C
    R I Med J (2013); 2024 Oct; 107(10):7-9. PubMed ID: 39331004
    [No Abstract]   [Full Text] [Related]  

  • 56. A review of dupilumab in the treatment of atopic diseases.
    Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
    Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two is better than one: Effectiveness of dupilumab on atopic dermatitis and chronic rhinosinusitis with nasal polyps in an adolescent.
    Patruno C; Nocerino M; Maffei M; Menna L; Fornaro L; Fabbrocini G; Napolitano M
    Dermatol Ther; 2022 Nov; 35(11):e15857. PubMed ID: 36153306
    [No Abstract]   [Full Text] [Related]  

  • 58. Dupixent® (Dupilumab): A Newly Approved Interleukin-4 Receptor Antagonist for the Treatment of Atopic Dermatitis in Pediatric Patients.
    Gupta AK; Love RP; Abramovits W; Vincent KD
    Skinmed; 2019; 17(2):107-109. PubMed ID: 31145061
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study.
    Jo CE; Georgakopoulos JR; Ladda M; Ighani A; Mufti A; Drucker AM; Piguet V; Yeung J
    J Am Acad Dermatol; 2020 Jun; 82(6):1530-1532. PubMed ID: 32074486
    [No Abstract]   [Full Text] [Related]  

  • 60. Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis.
    Ayasse M; Nelson K; Glass F; Silverberg JI
    Dermatitis; 2021 Oct; 32(1S):e88-e89. PubMed ID: 33273230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.